LEUKEMIA

Publications

  1. 2009
  2. Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

    Brüggemann, M., Schrauder, A., Raff, T., Pfeifer, H., Dworzak, M., Ottmann, O. G., Asnafi, V., Baruchel, A., Bassan, R., Benoit, Y., Biondi, A., Cavé, H., Dombret, H., Fielding, A. K., Foà, R., Gökbuget, N., Goldstone, A. H., Goulden, N., Henze, G., Hoelzer, D., Janka-Schaub, G., Macintyre, E. A., Pieters, R., Rambaldi, A., Ribera, J-M., Schmiegelow, K., Spinelli, O., Stary, J., von Stackelberg, A., Kneba, M., Schrappe, M. & van Dongen, J. J. M., 2009, In: LEUKEMIA.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2008
  4. Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis

    Müller, I., Vaegler, M., Holzwarth, C., Tzaribatchev, N., Pfister, S. M., Schütt, B., Reize, P., Greil, J., Handgretinger, R. & Rudert, M., 11.2008, In: LEUKEMIA. 22, 11, p. 2054-61 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration

    Chapuy, B., Koch, R., Radunski, U., Corsham, S., Cheong, N., Inagaki, N., Ban, N., Wenzel, D., Reinhardt, D., Zapf, A., Schweyer, S., Kosari, F., Klapper, W., Truemper, L. & Wulf, G. G., 08.2008, In: LEUKEMIA. 22, 8, p. 1576-1586 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment.

    Schnittger, S., Bacher, U., Kern, W., Haferlach, T., Hertenstein, B. & Haferlach, C., 2008, In: LEUKEMIA. 22, 4, p. 856-858 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Choosing between stem cell therapy and drugs in myelofibrosis.

    Kröger, N. & Mesa, R. A., 2008, In: LEUKEMIA. 22, 3, p. 474-486 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.

    Van Vlierberghe, P., Homminga, I., Zuurbier, L., Gladdines-Buijs, J., van Wering, E. R., Horstmann, M., Beverloo, H. B., Pieters, R. & Meijerink, J. P. P., 2008, In: LEUKEMIA. 22, 4, p. 762-770 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Detection of an MPLW515 mutation in a case with features of both essential thrombocythemia and refractory anemia with ringed sideroblasts and thrombocytosis.

    Schnittger, S., Bacher, U., Haferlach, C., Dengler, R., Kröber, A., Kern, W. & Haferlach, T., 2008, In: LEUKEMIA. 22, 2, p. 453-455 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.

    Cortes, J., Kim, D-W., Raffoux, E., Martinelli, G., Ritchie, E., Roy, L., Coutre, S., Corm, S., Hamerschlak, N., Tang, J-L., Hochhaus, A., Khoury, H. J., Brümmendorf, T., Michallet, M., Rege-Cambrin, G., Gambacorti-Passerini, C., Radich, J. P., Ernst, T., Zhu, C., Van Tornout, J. M. A. & Talpaz, M., 2008, In: LEUKEMIA. 22, 12, p. 2176-2183 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.

    Schilling, G., Hansen, T., Shimoni, A., Zabelina, T., Pérez-Simón, J-A., Simon-Perez, J-A., Gutierrez, N. C., Fiedler, W., Liebisch, P., Schwerdtfeger, R., Bornhäuser, M., Otterstetter, S., Murga-Penas, E-M., Dierlamm, J., Ayuketang Ayuk, F., Atanackovic, D., Bacher, U., Bokemeyer, C., Zander, A. R., San Miguel, J., Miguel, J. S., Nagler, A. & Kröger, N., 2008, In: LEUKEMIA. 22, 6, p. 1250-1255 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Induction of Toll-like receptor 2 and 4 expression on CD4+ and CD8+ T cells in G-CSF-mobilized unrelated peripheral blood stem cell grafts during leukapheresis: impact on patient outcome.

    Platzbecker, U., Stoehlmacher, J., Pabst, C., Goekkurt, E., Oelschlägel, U., Schirutschke, H., Hölig, K., Theuser, C., Mogck, U., Ehninger, G. & Bornhäuser, M., 2008, In: LEUKEMIA. 22, 7, p. 1438-1440 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes.

    Buesche, G., Teoman, H., Wilczak, W., Ganser, A., Hecker, H., Wilkens, L., Göhring, G., Schlegelberger, B., Bock, O., Georgii, A. & Kreipe, H., 2008, In: LEUKEMIA. 22, 2, p. 313-322 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.

    Van Vlierberghe, P., Beverloo, H. B., Buijs-Gladdines, J., van Wering, E. R., Horstmann, M., Pieters, R. & Meijerink, J. P. P., 2008, In: LEUKEMIA. 22, 7, p. 1434-1437 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation.

    Benjamini, O., Koren-Michowitz, M., Amariglio, N., Kröger, N., Nagler, A. & Shimoni, A., 2008, In: LEUKEMIA. 22, 10, p. 1961-1963 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Time-course-dependent microvascular alterations in a model of myeloid leukemia in vivo.

    Schäfer, C., Krause, M., Fuhrhop, I., Schröder, M., Algenstaedt, P., Fiedler, W., Rüther, W. & Hansen-Algenstaedt, N., 2008, In: LEUKEMIA. 22, 1, p. 59-65 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. 2007
  18. Leukemia-targeting ligands isolated from phage-display peptide libraries

    Jäger, S., Jahnke, A., Wilmes, T., Adebahr, S., Vögtle, F-N., Delima-Hahn, E., Pfeifer, D., Berg, T., Lübbert, M. & Trepel, M., 03.2007, In: LEUKEMIA. 21, 3, p. 411-20 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

    van der Velden, V. H. J., Cazzaniga, G., Schrauder, A., Hancock, J., Bader, P., Panzer-Grumayer, E. R., Flohr, T., Sutton, R., Cave, H., Madsen, H. O., Cayuela, J. M., Trka, J., Eckert, C., Foroni, L., Zur Stadt, U., Beldjord, K., Raff, T., van der Schoot, C. E. & van Dongen, J. J. M., 2007, In: LEUKEMIA. 21, 4, p. 604-611 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Detecting the JAK2 V617F mutation in fresh and 'historic' blood and bone marrow.

    Gattenlohner, S., Peter, C., Bonengel, M., Einsele, H., Bargou, R., Müller-Hermelink, H-K. & Marx, A., 2007, In: LEUKEMIA. 21, 7, p. 1599-1602 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.

    Schnittger, S., Bacher, U., Kern, W., Haferlach, C. & Haferlach, T., 2007, In: LEUKEMIA. 21, 1, p. 183-184 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases.

    Schnittger, S., Bacher, U., Kern, W., Haferlach, T. & Haferlach, C., 2007, In: LEUKEMIA. 21, 8, p. 1843-1845 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation.

    Kröger, N., 2007, In: LEUKEMIA. 21, 9, p. 1851-1858 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.

    Schnittger, S., Bacher, U., Haferlach, C., Kern, W. & Haferlach, T., 2007, In: LEUKEMIA. 21, 4, p. 725-731 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA.

    Meyer, J., Rhein, M., Schiedlmeier, B., Kustikova, O., Rudolph, C., Kamino, K., Neumann, T., Yang, M., Wahlers, A., Fehse, B., Reuther, G. W., Schlegelberger, B., Ganser, A., Baum, C. & Li, Z., 2007, In: LEUKEMIA. 21, 10, p. 2171-2180 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. 2006
  27. Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia.

    Meier, M., Den, B., Meijerink, U., Broekhuis, U., Passier, U., Wering, V., Janka-Schaub, G. & Pieters, R., 2006, In: LEUKEMIA. 20, 8, p. 1377-1384 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.

    Stams, U., Beverloo, U., Den, B., Menezes, D., Stigter, U., Drunen, V., Ramakers-van-Woerden, U., Loonen, U., Wering, V., Janka-Schaub, G. & Pieters, R., 2006, In: LEUKEMIA. 20, 3, p. 410-416 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia.

    Stam, U., Den, B., Passier, U., Janka-Schaub, G., Sallan, U., Armstrong, U. & Pieters, R., 2006, In: LEUKEMIA. 20, 2, p. 264-271 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. 2005
  31. Antiangiogenic treatment with endostatin inhibits progression of AML in vivo.

    Schuch, G., Oliveira-Ferrer, L., Loges, S., Laack, E., Bokemeyer, C., Hossfeld, D. K., Fiedler, W. & Ergun, S., 2005, In: LEUKEMIA. 19, 8, p. 1312-1317 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.

    Shimoni, A., Kröger, N-M., Zabelina, T., Ayuketang Ayuk, F., Hardan, I., Yeshurun, M., Shem-Tov, N., Avigdor, A., Ben-Bassat, I., Zander, A. & Nagler, A., 2005, In: LEUKEMIA. 19, 1, p. 7-12 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.

    Baron, F., Maris, M. B., Storer, B. E., Sandmaier, B. M., Panse, J., Chauncey, T. R., Sorror, M., Little, M-T., Maloney, D. G., Storb, R. & Heimfeld, S., 2005, In: LEUKEMIA. 19, 5, p. 822-828 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.

    Meier, M., den Boer, M. L., Hall, A. G., Irving, J. A. E., Passier, M., Minto, L., van Wering, E. R., Janka-Schaub, G. & Pieters, R., 2005, In: LEUKEMIA. 19, 11, p. 1887-1895 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells.

    Bardenheuer, W., Lehmberg, K., Rattmann, I., Brueckner, A., Schneider, A., Sorg, U. R., Seeber, S., Moritz, T. & Flasshove, M., 2005, In: LEUKEMIA. 19, 12, p. 2281-2288 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005.

    Aricó, M., Baruchel, A., Bertrand, Y., Biondi, A., Conter, V., Eden, T., Gadner, H., Gaynon, P., Horibe, K., Hunger, S. P., Janka-Schaub, G., Masera, G., Nachman, J., Pieters, R., Schrappe, M., Schmiegelow, K., Valsecchi, M. G. & Pui, C-H., 2005, In: LEUKEMIA. 19, 7, p. 1145-1152 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. 2004
  38. Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.

    Ayuketang Ayuk, F., Shimoni, A., Nagler, A., Schwerdtfeger, R., Kiehl, M., Sayer, H. G., Zabelina, T., Zander, A. R. & Kröger, N., 2004, In: LEUKEMIA. 18, 3, p. 659-662 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.

    Woerden, R., Beverloo, U., Veerman, U., Camitta, U., Loonen, U., Wering, V., Slater, U., Harbott, J., Den, B., Ludwig, U., Haas, U., Janka-Schaub, G. & Pieters, R., 2004, In: LEUKEMIA. 18, 3, p. 521-529 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.

    Stam, U., van Den, H-E., Den, B., Ebus, U., Janka-Schaub, G., Allen, U. & Pieters, R., 2004, In: LEUKEMIA. 18, 1, p. 78-83 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.

    Horn, S., Endl, E., Fehse, B., Weck, M. M., Mayr, G. W. & Jücker, M., 2004, In: LEUKEMIA. 18, 11, p. 1839-1849 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.

    Heerema, N. A., Harbott, J., Galimberti, S., Camitta, B. M., Gaynon, P. S., Janka-Schaub, G., Kamps, W., Basso, G., Pui, C-H., Schrappe, M., Auclerc, M-F., Carroll, A. J., Conter, V., Harrison, C. J., Pullen, J., Raimondi S, C., Richards, S., Riehm, H., Sather, H. N., Shuster, J. J., Silverman, L. B., Valsecchi, M. G. & Aricò, M., 2004, In: LEUKEMIA. 18, 4, p. 693-702 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. 2003
  44. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.

    Pui, C-H., Chessells, J. M., Camitta, B., Baruchel, A., Biondi, A., Boyett, J. M., Carroll, A., Eden, O. B., Evans, W. E., Gadner, H., Harbott, J., Harms, D. O., Harrison, C. J., Harrison, P. L., Heerema, N., Janka-Schaub, G., Kamps, W., Masera, G., Pullen, J., Raimondi S, C., Richards, S., Riehm, H., Sallan, S., Sather, H., Shuster, J., Silverman, L. B., Valsecchi, M. G., Vilmer, E., Zhou, Y., Gaynon, P. S. & Schrappe, M., 2003, In: LEUKEMIA. 17, 4, p. 700-706 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas.

    Murga-Penas, E-M., Hinz, K., Röser, K., Copie-Bergman, C., Wlodarska, I., Marynen, P., Hagemeijer, A., Gaulard, P., Löning, T., Hossfeld, D. K. & Dierlamm, J., 2003, In: LEUKEMIA. 17, 11, p. 2225-2229 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. 2002
  47. Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell

    Li, Z., Fehse, B., Schiedlmeier, B., Düllmann, J., Frank, O., Zander, A. R., Ostertag, W. & Baum, C., 09.2002, In: LEUKEMIA. 16, 9, p. 1655-63 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases.

    Borkhardt, A., Wuchter, C., Viehmann, S., Pils, S., Teigler-Schlegel, A., Stanulla, M., Zimmermann, M., Ludwig, W-D., Janka-Schaub, G., Schrappe, M. & Harbott, J., 2002, In: LEUKEMIA. 16, 9, p. 1685-1690 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. In vitro glucocorticoid resistance in childhood leukemia correlates with receptor affinity determined at 37 degrees C, but not with affinity determined at room temperature.

    Haarman, U., Kaspers, U., Pieters, R., Rottier, U., Den, B., Janka-Schaub, G. & Veerman, U., 2002, In: LEUKEMIA. 16, 9, p. 1882-1884 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. The novel t(11;12;18)(q21;q13;q21) represents a variant translocation of the t(11;18)(q21;q21) associated with MALT-type lymphoma.

    Dierlamm, J., Murga-Penas, E-M., Daibata, M., Tagushi, H., Hinz, K., Baens, M., Cools, J., Schilling, G., Michaux, L., Marynen, P., Miyoshi, I. & Hossfeld, D. K., 2002, In: LEUKEMIA. 16, 9, p. 1863-1864 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. 2001
  52. The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro

    Horn, S., Meyer, J., Heukeshoven, J., Fehse, B., Schulze, C., Li, S., Frey, J., Poll, S., Stocking, C. & Jücker, M., 01.2001, In: LEUKEMIA. 15, 1, p. 112-20 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen.

    Zur Stadt, U., Harms, D. O., Schlüter, S., Schrappe, M., Goebel, U., Spaar, H., Janka-Schaub, G. & Kabisch, H., 2001, In: LEUKEMIA. 15, 2, p. 283-285 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. 2000
  55. Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92.

    Harms, D. O. & Janka-Schaub, G., 2000, In: LEUKEMIA. 14, 12, p. 2234-2239 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  56. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia.

    Schrappe, M., Camitta, B., Pui, C. H., Eden, T., Gaynon, P., Gustafsson, G., Janka-Schaub, G., Kamps, W., Masera, G., Sallan, S., Tsuchida, M. & Vilmer, E., 2000, In: LEUKEMIA. 14, 12, p. 2193-2194 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  57. The common deletion 657del5 in the Nibrin gene is not a major risk factor for B or T cell non-Hodgkin lymphoma in a pediatric population.

    Rischewski, J., Bismarck, P., Kabisch, H., Janka-Schaub, G., Obser, T. & Schneppenheim, R., 2000, In: LEUKEMIA. 14, 8, p. 1528-1529 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  58. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.

    Kordes, U., Krappmann, D., Heissmeyer, V., Ludwig, W. D. & Scheidereit, C., 2000, In: LEUKEMIA. 14, 3, p. 399-402 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  59. 1999
  60. A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies.

    Niehues, T., Kapaun, P., Harms, D. O., Burdach, S., Kramm, C., Körholz, D., Janka-Schaub, G. & Göbel, U., 1999, In: LEUKEMIA. 13, 4, p. 614-617 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  61. Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia.

    Den Boer, M. L., Pieters, R., Kazemier, K. M., Janka-Schaub, G., Henze, G. & Veerman, A. J., 1999, In: LEUKEMIA. 13, 12, p. 2023-2030 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review